Cistron Biotechnology(CIST)$.30 Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: AgAuUSA who wrote (116)	11/15/1996 12:45:00 AM
From: scaram(o)uche	of 2742

Message from greg pfau on Nov 14 1996 7:58PM EST I believe the information indicates IL-1 needs alot of work to become fully valued. It appears to me that IMNX all but abandoned work on IL1 after the late 1980's or early 1990's in favor of work on the IL-1 receptor. As I indicated earlier, Imnx has a Ph I clinical trial of IL-l receptor ongoing. ////////////////////////////////////////// You're kidding?? You mean that Immunex has zero, nichts, nada and zilch interest in IL-1beta?? I could have sworn that I just said that. But, thanks, Dr. Pfau.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next